Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Cash from Financing Activities (2016 - 2020)

Historic Cash from Financing Activities for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $42.4 million.

  • Forte Biosciences' Cash from Financing Activities changed N/A to $42.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $66.7 million, marking a year-over-year increase of 127287.89%. This contributed to the annual value of $51.9 million for FY2024, which is 11008.35% up from last year.
  • Per Forte Biosciences' latest filing, its Cash from Financing Activities stood at $42.4 million for Q4 2020.
  • In the past 5 years, Forte Biosciences' Cash from Financing Activities ranged from a high of $87.2 million in Q2 2017 and a low of -$1.8 million during Q3 2017
  • In the last 5 years, Forte Biosciences' Cash from Financing Activities had a median value of $968000.0 in 2019 and averaged $12.8 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 37905217.39% in 2017, then plummeted by 13379.13% in 2018.
  • Forte Biosciences' Cash from Financing Activities (Quarter) stood at -$23000.0 in 2016, then tumbled by 5726.09% to -$1.3 million in 2017, then surged by 2228.21% to $28.5 million in 2018, then plummeted by 89.18% to $3.1 million in 2019, then skyrocketed by 1273.72% to $42.4 million in 2020.
  • Its Cash from Financing Activities was $42.4 million in Q4 2020, compared to $166000.0 in Q3 2020 and $24.1 million in Q2 2020.